EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeting CTP synthetase 1 to restore interferon induction and impede nucleotide synthesis in SARS-CoV-2 infection

Youliang Rao, Chao Qin iD, Bianca Espinosa, Ting-Yu Wang, Shu Feng, Ali Can Savas, Jill Henley, Lucio Comai, Chao Zhang, Pinghui Feng iD

mBio · 2025

DOI: 10.1128/mbio.00649-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2025. Verfasst von Youliang Rao und 9 weiteren Autor:innen. Beteiligte Einrichtung: Section of Infection and Immunity, Herman Ostrow School of Dentistry, University of Southern California, Los Angeles, California, USA. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19, Interferons, Carbon-Nitrogen Ligases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, National Institute of Allergy and Infectious Diseases, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the global impact caused by the most recent SARS-CoV-2 pandemic, our knowledge of the molecular underpinnings of its highly infectious nature remains incomplete. We report here that SARS-CoV-2 exploits cellular CTP synthetase 1 (CTPS1) to promote CTP synthesis and suppress interferon (IFN) induction. In addition to catalyzing CTP synthesis, CTPS1 also deamidates interferon regulatory factor 3 (IRF3) to dampen interferon induction. Screening a SARS-CoV-2 expression library, we identified several viral proteins that interact with CTPS1. Functional analyses demonstrate that ORF8 and Nsp8 activate CTPS1 to deamidate IRF3 and negate IFN induction, whereas ORF7b and ORF8 activate CTPS1 to promote CTP synthesis. These results highlight CTPS1 as a signaling node that integrates cellular metabolism and innate immune response. Indeed, small-molecule inhibitors of CTPS1 deplete CTP and boost IFN induction in SARS-CoV-2-infected cells, thus effectively impeding SARS-CoV-2 replication and pathogenesis in mouse models. Our work uncovers an intricate mechanism by which a viral pathogen couples immune evasion to metabolic activation to fuel viral replication. Inhibition of the cellular CTPS1 offers an attractive means to develop antiviral therapy against highly mutagenic viruses. IMPORTANCE Our understanding of the underpinnings of highly infectious SARS-CoV-2 is rudimentary at best. We report here that SARS-CoV-2 activates CTPS1 to promote CTP synthesis and suppress IFN induction, thus coupling immune evasion to activated nucleotide synthesis. Inhibition of the key metabolic enzyme not only depletes the nucleotide pool but also boosts host antiviral defense, thereby impeding SARS-CoV-2 replication. Targeting cellular enzymes presents a strategy to counter the rapidly evolving SARS-CoV-2 variants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19InterferonsCarbon-Nitrogen LigasesNucleotidesHumansAnimalsMiceVirus ReplicationInterferon Regulatory Factor-3Viral ProteinsCOVID-19 Drug TreatmentImmunity, InnateAntiviral AgentsHEK293 CellsVero CellsCytidine Triphosphate

Stichwörter der Autor:innen

CTPS1SARS-CoV-2antiviral pharmacologyinterferonpyrimidine metabolism

Substanzen

CTP synthetaseInterferonsCarbon-Nitrogen LigasesInterferon Regulatory Factor-3Viral ProteinsNucleotidesAntiviral AgentsIRF3 protein, humanCytidine Triphosphate

Autor:innen und Institutionen

  • Section of Infection and Immunity, Herman Ostrow School of Dentistry, University of Southern California, Los Angeles, California, USA.
  • Department of Chemistry, Dornsife College of Arts, Letters and Sciences, University of Southern California, Los Angeles, California, USA.
  • Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.

ORCID-Profile: Chao Qin, Pinghui Feng

Förderung

  • NCI NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • NIA NIH HHS
  • NIAID NIH HHS
  • National Institute of Aging
  • National Cancer Institute

Zitieren

APA

Rao, Y., Qin, C., Espinosa, B., Wang, T. Y., Feng, S., Savas, A. C., Henley, J., Comai, L., Zhang, C., & Feng, P. (2025). Targeting CTP synthetase 1 to restore interferon induction and impede nucleotide synthesis in SARS-CoV-2 infection. mBio. https://doi.org/10.1128/mbio.00649-25

Vancouver

Rao Y, Qin C, Espinosa B, Wang TY, Feng S, Savas AC, et al. Targeting CTP synthetase 1 to restore interferon induction and impede nucleotide synthesis in SARS-CoV-2 infection. mBio. 2025. doi:10.1128/mbio.00649-25

BibTeX
@article{Rao2025,
  author = {Rao, Youliang and Qin, Chao and Espinosa, Bianca and Wang, Ting-Yu and Feng, Shu and Savas, Ali Can and Henley, Jill and Comai, Lucio and Zhang, Chao and Feng, Pinghui},
  title = {Targeting CTP synthetase 1 to restore interferon induction and impede nucleotide synthesis in SARS-CoV-2 infection},
  journal = {mBio},
  year = {2025},
  doi = {10.1128/mbio.00649-25}
}
Kostenlos starten →